A chemosensitization screen identifies TP53RK, a kinase that restrains apoptosis after mitotic stress

Cancer Research
David PetersonLisa D Belmont

Abstract

Taxanes are very effective at causing mitotic arrest; however, there is variability among cancer cells in the apoptotic response to mitotic arrest. The variability in clinical efficacy of taxane-based therapy is likely a reflection of this variability in apoptotic response, thus elucidation of the molecular mechanism of the apoptotic response to mitotic stress could lead to improved clinical strategies. To identify genes whose expression influences the rate and extent of apoptosis after mitotic arrest, we screened a kinase-enriched small interfering RNA library for effects on caspase activation in response to maximally effective doses of paclitaxel, a PLK1 inhibitor, or cisplatin. Small interfering RNA oligonucleotides directed against an atypical protein kinase, TP53RK, caused the greatest increase in caspase-3/7 activation in response to antimitotic agents. Time-lapse microscopy revealed that cells entered mitosis with normal kinetics, but died after entry into mitosis in the presence of paclitaxel more rapidly when TP53RK was depleted. Because expression levels of TP53RK vary in cancers, TP53RK levels could provide a molecular marker to predict response to antimitotic agents. TP53RK inhibition may also sensitize cancers to t...Continue Reading

References

Sep 18, 1996·Journal of the National Cancer Institute·C G MilrossL Milas
Nov 7, 1998·The Journal of Biological Chemistry·C D ScatenaJ A Pietenpol
Mar 23, 2002·Science·Thijn R BrummelkampReuven Agami
Feb 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kui Lei, Roger J Davis
Apr 3, 2004·Cancer Research·Tamotsu SudoNaoto T Ueno
Dec 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Zhanyun TangHongtao Yu
Apr 28, 2005·Current Topics in Medicinal Chemistry·Gustave BergnesLisa Belmont
Jan 21, 2006·Cancer Research·Klaus P HoeflichSomasekar Seshagiri
Aug 17, 2006·Cancer Research·Maria CapraPier Paolo Di Fiore
Jan 26, 2007·Nature Reviews. Cancer·Jeffrey R JacksonPearl S Huang
Feb 13, 2007·Current Biology : CB·Martin SteegmaierWolfgang J Rettig
Feb 27, 2007·Oncogene·J M Adams, S Cory
Apr 13, 2007·Nature·Angelique W WhitehurstMichael A White
May 1, 2007·Molecular Cell·Lindsey A Allan, Paul R Clarke
Jul 4, 2007·Journal of Cell Science·Dongli HuJill M Lahti
Aug 19, 2007·Medicinal Research Reviews·Rongshi Li, Stephan W Morris
Aug 23, 2007·Cellular and Molecular Life Sciences : CMLS·S FacchinL A Pinna
Sep 28, 2007·BMC Biotechnology·Daniel C GrayDavid P Davis
Mar 5, 2008·The Journal of Cell Biology·Hideki YokoyamaEric Karsenti
Jan 20, 2009·Molecular Cell·Elinor DehanMichele Pagano
Sep 5, 2009·The EMBO Journal·Joshua L AndersenSally Kornbluth
Jan 28, 2010·Molecular Cancer Therapeutics·Shanghua YinFernando Cabral
Feb 12, 2010·Nature Reviews. Cancer·Maria Kavallaris

❮ Previous
Next ❯

Citations

May 27, 2011·Molecular Biology of the Cell·Kyunghee LeeConly L Rieder
Apr 5, 2011·Nucleic Acids Research·Mitsunori KayanoHiroshi Mamitsuka
Jun 14, 2014·Cell Death and Differentiation·S ZaccaraA Inga
Dec 8, 2011·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Vincenzo SollazzoFrancesco Carinci
Apr 19, 2015·Molecular Cancer·Dag Andre NymoenBen Davidson
Feb 23, 2012·Cancer Biology & Therapy·Weihong ZhaoQimin Zhan
Aug 15, 2017·Nature Genetics·Daniela A BraunFriedhelm Hildebrandt
Dec 17, 2015·Expert Review of Hematology·Nicole L BlanchetteSuzy V Torti
Oct 10, 2012·Oncotarget·Jantine PosthumadeboerVictor W van Beusechem
Jun 16, 2018·Oncogene·Eunmiri RohZigang Dong
Jun 14, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Yan ZhaoMarlin Touma
Feb 4, 2012·Molecular Cancer Therapeutics·Maureen WongLisa D Belmont
Feb 28, 2018·Molecular Cancer Therapeutics·Tatyana ZykovaZigang Dong
Jan 12, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nguyen TanLisa D Belmont
May 16, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey J WallinDeepak Sampath

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology
Indrajit ChowdhuryGanapathy K Bhat
Genome Research
Frédéric CollandJean-Michel Gauthier
© 2021 Meta ULC. All rights reserved